KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Gains from Sales and Divestitures (2016)

AbbVie has reported Gains from Sales and Divestitures over the past 4 years, most recently at $6.1 million for Q2 2016.

  • Quarterly Gains from Sales and Divestitures rose 11.16% to $6.1 million in Q2 2016 from the year-ago period, while the trailing twelve-month figure was $6.1 million through Jun 2016, up 11.16% year-over-year, with the annual reading at $5.7 million for FY2015, 14.1% down from the prior year.
  • Gains from Sales and Divestitures was $6.1 million for Q2 2016 at AbbVie, up from $5.5 million in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $7.6 million in Q4 2013 and troughed at $5.3 million in Q1 2015.
  • The 4-year median for Gains from Sales and Divestitures is $6.3 million (2014), against an average of $6.4 million.
  • Year-over-year, Gains from Sales and Divestitures dropped 14.53% in 2015 and then grew 11.16% in 2016.
  • A 4-year view of Gains from Sales and Divestitures shows it stood at $7.6 million in 2013, then decreased by 12.11% to $6.6 million in 2014, then decreased by 14.1% to $5.7 million in 2015, then increased by 7.65% to $6.1 million in 2016.
  • Per Business Quant, the three most recent readings for ABBV's Gains from Sales and Divestitures are $6.1 million (Q2 2016), $5.5 million (Q1 2016), and $5.7 million (Q4 2015).